Follow the 프로티나 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 프로티나 has recorded 10 public disclosures. Market capitalisation: €228.9bn. The latest transaction was reported on 30 April 2026 (Purchase). Among the most active insiders: 최병산. Every trade is accessible without an account.
10
Insider Decl.
n/a
Thresholds
€618,771
9 ops.
Buy Volume
n/a
n/a
Sell Volume
19Σ signal
Buys €618,771n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Protinah is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It specializes in the development of innovative pharmaceutical products.